• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Kidney Injury Molecule-1 as a Urinary Biomarker for Aminoglycoside Induced Acute Kidney Injury, among Non-Critically Ill Children: Authors' Reply.

作者信息

George Maria, Pillai Kalyani, Suseela K V

机构信息

Department of Pediatrics, Amala Institute of Medical Sciences, Thrissur, Kerala, 680555, India.

Department of Microbiology, Amala Institute of Medical Sciences, Thrissur, Kerala, 680555, India.

出版信息

Indian J Pediatr. 2025 Apr;92(4):441. doi: 10.1007/s12098-025-05431-y. Epub 2025 Jan 30.

DOI:10.1007/s12098-025-05431-y
PMID:39883397
Abstract
摘要

相似文献

1
Kidney Injury Molecule-1 as a Urinary Biomarker for Aminoglycoside Induced Acute Kidney Injury, among Non-Critically Ill Children: Authors' Reply.肾损伤分子-1作为非危重症儿童氨基糖苷类药物所致急性肾损伤的尿液生物标志物：作者回复
Indian J Pediatr. 2025 Apr;92(4):441. doi: 10.1007/s12098-025-05431-y. Epub 2025 Jan 30.
2
Kidney Injury Molecule-1 as a Urinary Biomarker for Aminoglycoside Induced Acute Kidney Injury, among Non-Critically Ill Children: Correspondence.肾损伤分子-1作为非危重症儿童氨基糖苷类药物所致急性肾损伤的尿液生物标志物：通信
Indian J Pediatr. 2025 Apr;92(4):440. doi: 10.1007/s12098-025-05430-z. Epub 2025 Jan 23.
3
Kidney Injury Molecule-1 as a Urinary Biomarker for Aminoglycoside Induced Acute Kidney Injury, among Non-Critically Ill Children.肾损伤分子-1作为非危重症儿童氨基糖苷类药物所致急性肾损伤的尿液生物标志物
Indian J Pediatr. 2024 Jul;91(7):742. doi: 10.1007/s12098-023-04987-x. Epub 2023 Dec 16.
4
Kidney injury molecule-1/creatinine as a urinary biomarker of acute kidney injury in critically ill neonates.肾损伤分子-1/肌酐作为危重新生儿急性肾损伤的尿液生物标志物
J Pediatr Urol. 2020 Oct;16(5):688.e1-688.e9. doi: 10.1016/j.jpurol.2020.06.030. Epub 2020 Jul 2.
5
Derivation and validation of urinary TIMP-1 for the prediction of acute kidney injury and mortality in critically ill children.尿 TIMP-1 预测危重症儿童急性肾损伤和死亡的推导和验证。
J Transl Med. 2022 Feb 23;20(1):102. doi: 10.1186/s12967-022-03302-0.
6
Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock.血清中性粒细胞明胶酶相关脂质运载蛋白（NGAL）作为脓毒性休克危重症患儿急性肾损伤的标志物。
Crit Care Med. 2008 Apr;36(4):1297-303. doi: 10.1097/CCM.0b013e318169245a.
7
The role of biomarkers in early identification of acute kidney injury among non-critically ill patients.生物标志物在非危重症患者急性肾损伤早期识别中的作用。
J Nephrol. 2024 Jun;37(5):1327-1338. doi: 10.1007/s40620-024-01950-7. Epub 2024 Jun 5.
8
Epidemiology of acute kidney injury and the role of urinary [TIMP-2]·[IGFBP7]: a prospective cohort study in critically ill obstetric patients.急性肾损伤的流行病学及尿 [TIMP-2]·[IGFBP7] 的作用：一项针对危重症产科患者的前瞻性队列研究
Int J Obstet Anesth. 2018 Nov;36:77-84. doi: 10.1016/j.ijoa.2018.08.002. Epub 2018 Aug 24.
9
Urinary Neutrophil Gelatinase-Associated Lipocalin Predicts Renal Injury Following Extracorporeal Membrane Oxygenation.尿中性粒细胞明胶酶相关脂质运载蛋白可预测体外膜肺氧合术后的肾损伤。
Pediatr Crit Care Med. 2015 Sep;16(7):663-70. doi: 10.1097/PCC.0000000000000476.
10
Hsp72 is a novel biomarker to predict acute kidney injury in critically ill patients.热休克蛋白72（Hsp72）是预测危重症患者急性肾损伤的一种新型生物标志物。
PLoS One. 2014 Oct 14;9(10):e109407. doi: 10.1371/journal.pone.0109407. eCollection 2014.

本文引用的文献

1
Kidney Injury Molecule-1 as a Urinary Biomarker for Aminoglycoside Induced Acute Kidney Injury, among Non-Critically Ill Children.肾损伤分子-1作为非危重症儿童氨基糖苷类药物所致急性肾损伤的尿液生物标志物
Indian J Pediatr. 2024 Jul;91(7):742. doi: 10.1007/s12098-023-04987-x. Epub 2023 Dec 16.
2
Pediatric acute kidney injury: prevalence, impact and management challenges.小儿急性肾损伤：患病率、影响及管理挑战
Int J Nephrol Renovasc Dis. 2017 Mar 29;10:77-84. doi: 10.2147/IJNRD.S103785. eCollection 2017.
3
Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies.
肾损伤分子-1 在临床前生物标志物资格研究中优于传统的肾损伤生物标志物。
Nat Biotechnol. 2010 May;28(5):478-85. doi: 10.1038/nbt.1623.